SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 30th, 2009 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New York
THRESHOLD PHARMACEUTICALS, INC. WARRANTThreshold Pharmaceuticals Inc • September 30th, 2009 • Pharmaceutical preparations
Threshold Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, «Name_of_Investor» or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of «Warrants» shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $2.23 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and on or after the date hereof (the “Initial Exercise Date”) and through and including the date that is sixty (60) months from the date hereof (the “Expiration Date”), subject to the following terms and conditions. This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated as of September 29, 2009, by and among the Company and the Investors identified therein (the “P
SECOND AMENDMENT TO RIGHTS AGREEMENTRights Agreement • September 30th, 2009 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Second Amendment to the Preferred Shares Rights Agreement (this “Amendment”), dated as of September 29, 2009, between Threshold Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Mellon Investor Services LLC, a New Jersey limited liability company, as Rights Agent (the “Rights Agent”), amends that certain Preferred Shares Rights Agreement, dated as of August 8, 2006, as amended (the “Rights Agreement”), by and between the Company and the Rights Agent.
